Stockscreener 앱 받기
15.28
3.41%
-0.54
시간 외 거래:
15.28
Keros Therapeutics Inc 주식(KROS)의 최신 뉴스
Is Keros Therapeutics Inc. stock poised for growth2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Quantitative breakdown of Keros Therapeutics Inc. recent moveOptions Play & Weekly Chart Analysis and Guides - newser.com
Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Summary & Verified Technical Signals - newser.com
Keros Therapeutics Inc Stock Analysis and ForecastMarket Profile Overview & Double Digit Returns - earlytimes.in
Can Keros Therapeutics Inc. rally from current levelsSwing Trade & Weekly Hot Stock Watchlists - newser.com
What analysts say about Keros Therapeutics Inc stockInsider Selling Patterns & Affordable Trading Plans - earlytimes.in
Is Peeti Securities Limited Positioned to Benefit From Geographic ExpansionSector Performance Review & Achieve Triple Digit Returns - earlytimes.in
How to interpret RSI for Keros Therapeutics Inc. stockWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Can machine learning forecast Keros Therapeutics Inc. recoveryEarnings Overview Report & Long-Term Growth Portfolio Plans - newser.com
Will Keros Therapeutics Inc. bounce back from current support2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
What momentum indicators show for Keros Therapeutics Inc. stock2025 Analyst Calls & Trade Opportunity Analysis Reports - newser.com
Is Keros Therapeutics Inc a good long term investmentEconomic Indicators Overview & Affordable Market Investment - earlytimes.in
What drives Keros Therapeutics Inc stock priceContrarian Investment Ideas & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting - ADVFN
Keros Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is now a turning point for Keros Therapeutics Inc.Watch List & Reliable Price Breakout Alerts - newser.com
CEO Change: Whats next for National Storage Affiliates Trust stockMarket Trend Report & Weekly High Potential Stock Alerts - خودرو بانک
Layoff Watch: Is Liberty Global Ltd stock risky to hold now2025 Investor Takeaways & Entry and Exit Point Strategies - خودرو بانک
Acadian Asset Management LLC Invests $1.50 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
Goldman Sachs Group Inc. Buys 205,022 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
What indicators show strength in Keros Therapeutics Inc.July 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Insider Sell: Is Fifth Third Bancorp a defensive stockWeekly Market Summary & Real-Time Stock Entry Alerts - khodrobank.com
IPO Launch: Is Keros Therapeutics Inc. stock trending bullishTrade Risk Summary & Accurate Buy Signal Alerts - khodrobank.com
Quarterly Risk: Will Keros Therapeutics Inc. benefit from rising consumer demandJuly 2025 Momentum & AI Optimized Trade Strategies - خودرو بانک
Buybacks Report: Is WF International Limited stock forming a triangle patternJuly 2025 Action & Fast Entry High Yield Tips - khodrobank.com
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Trend Recap: Can BOWN expand into new marketsRate Hike & Expert Approved Momentum Trade Ideas - khodrobank.com
How to use Fibonacci retracement on Keros Therapeutics Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - newser.com
Is Keros Therapeutics Inc. stock trending bullishQuarterly Portfolio Review & Weekly High Return Forecasts - خودرو بانک
Aug Sentiment: Will Range Resources Corporation benefit from government policyInsider Buying & Expert Approved Momentum Ideas - خودرو بانک
Resistance Check: Is Keros Therapeutics Inc. stock good for income investorsWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
H.C. Wainwright Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
Buyout Rumor: What is the target price for Keros Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - خودرو بانک
Acadian Asset Management LLC Takes Position in Keros Therapeutics, Inc. $KROS - Defense World
Whale Trades: Should you buy the dip on Lobo EV Technologies Ltd2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
Stock Market Recap: Can Keros Therapeutics Inc weather a recessionJuly 2025 Sentiment & Low Risk High Reward Ideas - خودرو بانک
Aug Retail: Is Keros Therapeutics Inc. on track to beat earningsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - khodrobank.com
Buyout Rumor: What is the next catalyst for ACCSQuarterly Market Summary & AI Powered Buy/Sell Recommendations - خودرو بانک
Sarcopenia Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross - Barchart.com
Momentum Shift: Whats the fair value of Keros Therapeutics Inc stockMarket Growth Review & Low Drawdown Investment Strategies - خودرو بانک
New Highs: Does Keros Therapeutics Inc stock reflect fundamentals2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
Volume Summary: What is the next catalyst for Keros Therapeutics IncMarket Growth Report & Risk Controlled Daily Plans - khodrobank.com
Quarterly Earnings: Is RMSGW stock showing strong momentumJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - خودرو بانک
2.95%
1.63%
자본화:
|
볼륨(24시간):